VTRS Viatris Inc. - Common Stock
NASDAQ · Pharmaceuticals · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q अग 6, 2026
$17.60
· 52 सप्ताह की सीमा का %
· निम्न से ऊपर
· उच्च तक
$9.6952w निम्न
$18.4352w उच्च
P/E
-4.2
EPS
$-3.00
राजस्व
$14.30B
आपके बैज
52W रेंज
$10–$18
विश्लेषक रेटिंग
BUY
मूल्य लक्ष्य
$19
P/E
-4.2
ROE
-23.2%
शुद्ध लाभ मार्जिन
-24.6%
आपकी बैज स्ट्रिप खाली है — इस पेज पर कहीं भी एक मीट्रिक पिन करें।
VTRS स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$17.60
P/E
-4.2
EPS
$-3.00
राजस्व
$14.30B
ROE
-23.2%
D/E ऋण/इक्विटी (MRQ)
0.9
52W रेंज
$10–$18
VTRS स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
सीमा
बार
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
स्टॉक विभाजन
| एक्स-डेट | स्प्लिट | प्रकार |
|---|---|---|
| 9 अक्टूबर 2003 | 3-for-2 | फॉरवर्ड |
| 28 जनवरी 2003 | 3-for-2 | फॉरवर्ड |
| 16 अगस्त 1995 | 3-for-2 | फॉरवर्ड |
| 3 अगस्त 1992 | 2-for-1 | फॉरवर्ड |
Viatris Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community.
Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue. In 2026, Viatris ranked 100 on Time Magazine's World's Most Impactful Companies.
History
On November 16, 2020, Upjohn merged with Mylan in a Reverse Morris Trust transaction and changed its name to Viatris. At that time, Michael Goettler became chief executive officer. Following the combination, the company began trading on the NASDAQ using the ticker symbol VTRS. In December 2020, the company announced a cost-reducing restructuring plan that would impact up to 20% of its global workforce, or 9,000 jobs at its facilities around the world.
In 2021, Viatris was ranked 5th by Fortune on its annual "Change the World" list for having "transformed the treatment of HIV around the world in the [previous] five years through the first low-cost antiretroviral drug for first-line treatment of HIV and a children's version in the form of fruit-flavored tablets that dissolve in liquid. In February 2022, Viatris announced an agreement where it will contribute to Biocon Biologics its biosimilars portfolio and related commercial and operational capabilities in exchange for up to $3.335 billion, including a stake of at least 12.9% in Biocon Biologics. The transaction was completed in November 2022. In November 2022, the business agreed to acquire Oyster Point Pharma and Famy Life Sciences for an aggregate of $700–750 million to create an ophthalmology division. The acquisitions closed in January 2023.
From 2021 to 2025, Viatris was recognized by Forbes as one of the world's best employers and in 2021 by Newsweek as one of America's most responsible companies. On April 1, 2023, Scott A. Smith became Viatris' CEO, succeeding Michael Goettler. Smith previously served on the company's board since 2022. In April 2023, Viatris was recognized by LinkedIn as one of the 25 best companies to work for in India, and one of the 25 best companies offering career development in Ireland.In May 2023 and 2024, USA Today included Viatris in its list of 450 US companies that have reduced their greenhouse gas emissions intensity from 2019 to 2021. In June 2023, Viatris was named to the Forbes Global 2000 list of the world's largest companies. In October 2023, Viatris reached agreements to divest from almost all of its OTC business, its women’s healthcare business, and its India-based active pharmaceutical ingredients business for a total of about $3.6 billion.
In late December 2024, Viatris disclosed that the U.S. FDA had issued a warning letter and an import alert concerning the company's drug-making facility in Indore, India. The import alert affects 11 actively distributed products, which will no longer be accepted into the U.S. until the warning letter is lifted, while four products were conditionally exempted due to shortages. The violations cited by the FDA included subpar quality control and improper management of manufacturing defect. In response, the company announced that it has taken corrective and preventative actions.
Predecessors
The following is an illustration of the company's major mergers and acquisitions and historical predecessors:
Products
The company produces and sells a variety of medicines, with 1,400 approved therapeutic molecules in its portfolio. It owns brands (like Viagra, Xanax, Lipitor), generics, including branded and complex generics, biosimilars, and over-the-counter (OTC) drugs and active pharmaceutical ingredients. Viatris products cover therapeutic areas including cardiovascular, infectious disease, oncology, immunology, CNS and anesthesia, women's healthcare, diabetes and metabolism, gastroenterology, respiratory and allergy, and dermatology.
The following products have been newly launched or received regulatory approvals since Viatris was established include:
Dolutegravir: In December 2020, received FDA approval to treat children with HIV/AIDS in low to middle income countries. The formulation is strawberry-flavored to make it easier to give to children and was made available at a 75% discount compared to previous treatments.
Breyna (budesonide and formoterol fumarate dihydrate inhalation aerosol): In March 2022, received approval from the US FDA in March 2022 as the first generic version of Symbicort for the treatment of asthma and COPD.
GA Depot (long-acting version of glatiramer acetate): In August 2023, received New Drug Application acceptance from the US FDA as a once-monthly injection for the treatment of relapsing forms of multiple sclerosis.
Abacavir/dolutegravir/lamivudine: In September 2023, received tentative US FDA approval for a New Drug Application through the President's Emergency Plan for AIDS Relief (PEPFAR) for the treatment of HIV-1 infection in pediatric patients.
Ryzumvi (phentolamine ophthalmic solution 0.75%): In September 2023, received FDA approval for the treatment of mydriasis caused by adrenergic agonist or parasympatholytic agents or a combination of those drugs. It was previously known as Nyxol.
Partnerships
Following the formation of Viatris, the company became a member of the Biosimilars Forum, a trade organization that advocates for greater biosimilar usage. Viatris partnered with the American College of Cardiology, the NCD Alliance, and the World Heart Federation to create the NCD Academy, a platform to help fight non-communicable diseases around the world.
In December 2020, the company worked with Sesame Workshop to create resources to help children and their caregivers manage their social and emotional needs impacted by the COVID-19 pandemic. In April 2021, the company partnered with Atomo Diagnostics and Unitaid to expand access to HIV self-testing to 135 countries and lower the price of the tests by around 50%.
In February 2024, Viatris entered into an agreement with Idorsia to collaborate on global research and development and the commercialization rights to Phase 3 pharmaceuticals selatogrel, a cardiac medication, and cenerimod, a novel immunology medication used to treat systemic lupus erythematosus. The agreement includes the potential to add more assets in the future.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
क्षेत्रHealthcare
उद्योगPharmaceuticals
कर्मचारी30000
देशUS
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व$14.30B2018-12-31 → 2025-12-31
EPS$-3.002018-12-31 → 2025-12-31
फ्री कैश फ्लो$1.94B2025-12-31 → 2025-12-31
शुद्ध मार्जिन-24.6%2025-12-31 → 2025-12-31
मूल्यांकन और अनुपात
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | VTRS | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E | -4.25Y औसत ≈36.5 | ≈36.5 | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | VTRS | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| सकल मार्जिन (TTM) | 34.8% | · | · | · | |
| परिचालन मार्जिन (TTM) | -0.59% | · | 8.2% | कमजोर | |
| EBITDA मार्जिन (TTM) | 18.4% | · | 5.2% | कमजोर | |
| प्रीटैक्स मार्जिन (TTM) | -4.5% | · | 8.1% | कमजोर | |
| Net Profit Margin (शुद्ध लाभ मार्जिन) | -24.6% | · | 3.3% | कमजोर | |
| ROA | -8.9% | · | 5.9% | कमजोर | |
| ROE | -23.2% | · | 12.2% | कमजोर | |
| ROIC | -8.8% | · | -0.21% | कमजोर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | VTRS | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| ऋण / इक्विटी (MRQ) | 0.9 | · | 1.2 | कम ऋण | |
| वर्तमान अनुपात (MRQ) | 1.6 | · | 1.6 | अनुरूप | |
| Quick Ratio (त्वरित अनुपात) | 0.6 | · | 0.9 | कम तरलता | |
| दीर्घकालिक ऋण / इक्विटी (MRQ) | 0.8 | · | 1.2 | कम ऋण | |
| Interest Coverage (ब्याज कवरेज) | -5.7 | · | · | · |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | VTRS | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | -3.0%5Y औसत ≈5.6% | ≈5.6% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | -4.2%5Y औसत ≈-0.52% | ≈-0.52% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 3.7% | · | · | · | |
| EPS YoY | -97.1% | · | · | · | |
| Net Income YoY (शुद्ध आय YoY) | -97.4% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | VTRS | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.4 | · | 0.5 | कमजोर | |
| Inventory Turnover (इन्वेंटरी टर्नओवर) | 2.4 | · | 1.4 | शीर्ष स्तर | |
| Receivables Turnover (प्राप्य टर्नओवर) | 4.6 | · | 5.4 | कमजोर | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$476.7K | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
लाभांश यील्ड, भुगतान अनुपात, लाभांश इतिहास, 5Y CAGR
वार्षिक भुगतान≈$0.48
| एक्स-डेट | राशि | मुद्रा | यील्ड |
|---|---|---|---|
| अग 21, 2026 | $0.12 | USD | ≈2.9% |
| मई 22, 2026 | $0.12 | USD | ≈2.9% |
| मा 9, 2026 | $0.12 | USD | ≈3.4% |
| नव 24, 2025 | $0.12 | USD | ≈4.5% |
| अग 22, 2025 | $0.12 | USD | ≈4.5% |
| मई 23, 2025 | $0.12 | USD | ≈5.8% |
| मा 10, 2025 | $0.12 | USD | ≈5.1% |
| नव 22, 2024 | $0.12 | USD | ≈3.6% |
| अग 23, 2024 | $0.12 | USD | ≈4.1% |
| मई 23, 2024 | $0.12 | USD | ≈4.6% |
| मा 8, 2024 | $0.12 | USD | ≈3.9% |
| नव 22, 2023 | $0.12 | USD | ≈5.1% |
| अग 23, 2023 | $0.12 | USD | ≈4.4% |
| मई 23, 2023 | $0.12 | USD | ≈5.2% |
| मा 8, 2023 | $0.12 | USD | ≈4.5% |
| नव 22, 2022 | $0.12 | USD | ≈4.3% |
| अग 23, 2022 | $0.12 | USD | ≈4.6% |
| मई 23, 2022 | $0.12 | USD | ≈4.0% |
| फ़र 23, 2022 | $0.12 | USD | ≈3.1% |
| नव 22, 2021 | $0.11 | USD | ≈2.5% |
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
8.0%
अगली रिपोर्ट
नव 04, 2026
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | अग 6, 2026 | $0.69 | $0.61 | 12.6% |
| 31 मार्च 2026 | मई 6, 2026 | $0.59 | $0.51 | 15.2% |
| 31 दिसमबर 2025 | $0.57 | $0.54 | 4.8% | |
| 30 सितमबर 2025 | $0.67 | $0.63 | 5.8% | |
| 30 जून 2025 | $0.62 | $0.57 | 9.4% | |
| 31 मार्च 2025 | $0.50 | $0.50 | 0.14% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.30B | $14.74B | $15.43B | $16.26B | $17.89B | $11.95B | $11.50B | $11.43B | |
| Cost of Revenue | $9.29B | $9.12B | $8.99B | $9.77B | $12.31B | $8.15B | $7.60B | $7.43B | |
| Gross Profit | $5.01B | $5.62B | $6.44B | $6.50B | $5.58B | $3.80B | $3.90B | $4.00B | |
| R&D Expense | · | · | · | · | $751M | $555M | $640M | $704M | |
| SG&A Expense | $3.79B | $4.10B | $4.07B | $4.18B | $4.53B | $3.34B | $2.56B | $2.44B | |
| Operating Expenses | $7.68B | $5.61B | $5.67B | $4.88B | $5.61B | $4.01B | $3.18B | $3.10B | |
| Operating Income | $-2.66B | $10M | $766M | $1.61B | $-34M | $-211M | $716M | $906M | |
| Interest Expense | $471M | $550M | $573M | $592M | $636M | $498M | $517M | $542M | |
| Other Non-op | $-531M | $-83M | $10M | $1.79B | $6M | $-13M | $-44M | $-65M | |
| Pretax Income | $-3.67B | $-623M | $203M | $2.81B | $-664M | $-721M | $154M | $298M | |
| Income Tax | $-150M | $11M | $148M | $735M | $605M | $-51M | $138M | $-54M | |
| Net Income | $-3.51B | $-634M | $55M | $2.08B | $-1.27B | $-670M | $17M | $352M | |
| EPS (Basic) | $-3.00 | $-0.53 | $0.05 | $1.71 | $-1.05 | $-1.11 | $0.03 | $0.69 | |
| EPS (Diluted) | $-3.00 | $-0.53 | $0.05 | $1.71 | $-1.05 | $-1.11 | $0.03 | $0.68 | |
| Shares (Basic) | · | · | 1,200,300,000 | 1,212,100,000 | 1,208,800,000 | 601,200,000 | 515,700,000 | 514,500,000 | |
| Shares (Diluted) | · | · | 1,206,900,000 | 1,217,400,000 | 1,208,800,000 | 601,200,000 | 516,500,000 | 516,500,000 | |
| EBITDA | $135M | · | · | · | · | · | · | · |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.32B | $735M | $992M | $1.26B | $701M | $844M | $476M | $388M | |
| Short-term Investments | · | · | · | · | · | $39M | $27M | · | |
| Receivables | $3.03B | $3.22B | $3.70B | $3.81B | $4.27B | $4.84B | $3.06B | · | |
| Inventory | $4.00B | $3.85B | $3.47B | $3.52B | $3.98B | $5.47B | $2.67B | · | |
| Prepaid Expense | $1.44B | $1.71B | $2.03B | $1.81B | $1.96B | $1.71B | $552M | · | |
| Other Current Assets | $136M | $387M | $271M | $328M | $1.47B | $1.24B | $286M | · | |
| Current Assets | $9.79B | $9.52B | $12.98B | $10.64B | $10.90B | $12.87B | $6.76B | · | |
| PP&E (Net) | $2.61B | $2.67B | $2.76B | $3.02B | $3.19B | $3.46B | $2.15B | · | |
| PP&E (Gross) | $5.13B | $4.87B | $4.77B | $5.08B | $5.59B | $5.72B | $4.12B | · | |
| Accum. Depreciation | $2.52B | $2.20B | $2.01B | $2.06B | $2.40B | $2.26B | $1.97B | · | |
| Goodwill | $6.75B | $9.13B | $9.87B | $10.43B | $12.11B | $12.35B | $9.59B | $9.75B | |
| Intangibles | $15.10B | $17.07B | $19.18B | $22.61B | $26.13B | $29.68B | $11.65B | · | |
| Other Non-current Assets | $1.87B | $2.36B | $2.21B | $2.40B | $1.17B | $1.05B | $405M | · | |
| Total Assets | $37.19B | $41.50B | $47.69B | $50.02B | $54.84B | $61.55B | $31.26B | · | |
| Short-term Debt | · | · | · | $0 | $1.49B | $1.10B | $0 | · | |
| Current Liabilities | $7.09B | $5.78B | $7.78B | $6.75B | $9.88B | $10.56B | $5.57B | · | |
| Capital Leases | $178M | $179M | $165M | $181M | $201M | $230M | $176M | · | |
| Deferred Tax | $892M | $1.11B | $1.74B | $2.43B | $2.81B | $3.12B | $1.63B | · | |
| Other Non-current Liabilities | $2.01B | $1.94B | $1.52B | $1.76B | $1.93B | $2.48B | $961M | · | |
| Total Liabilities | $22.48B | $22.87B | $27.22B | $28.95B | $34.35B | $38.60B | $19.37B | · | |
| Long-term Debt | $14.41B | $14.05B | $18.13B | $19.27B | $21.59B | $24.74B | $12.72B | · | |
| Total Debt | $14.41B | · | · | · | · | · | · | · | |
| Common Stock | $12M | $12M | $12M | $12M | $12M | $12M | $6M | · | |
| Paid-in Capital | $18.80B | $18.92B | $18.81B | $18.65B | $18.54B | $18.44B | $8.64B | · | |
| Retained Earnings | $-388M | $3.42B | $4.64B | $5.18B | $3.69B | $5.36B | $6.03B | · | |
| Treasury Stock | $1.01B | $504M | $252M | $0 | $0 | $0 | $1000M | · | |
| AOCI | $-2.71B | $-3.21B | $-2.75B | $-2.76B | $-1.74B | $-858M | $-1.80B | · | |
| Stockholders' Equity | $14.71B | $18.64B | $20.47B | $21.07B | $20.49B | $22.95B | $11.88B | $12.17B | |
| Liabilities + Equity | $37.19B | $41.50B | $47.69B | $50.02B | $54.84B | $61.55B | $31.26B | · | |
| Shares Outstanding | · | · | · | · | · | · | 100 | · |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.80B | $2.89B | $2.74B | $3.03B | $4.51B | $2.22B | $2.02B | $2.11B | |
| Stock-based Comp | $178M | $146M | $181M | $116M | $111M | $79M | $57M | $-3M | |
| Deferred Tax | $-476M | $-768M | $-387M | $-26M | $676M | $-213M | $-193M | $-264M | |
| Amort. of Intangibles | $2.35B | $2.35B | $2.32B | $2.50B | $2.70B | $1.61B | $1.58B | $1.61B | |
| Restructuring | · | · | · | · | $50M | $50M | $105M | · | |
| Other Non-cash | $3.33B | · | · | · | · | · | · | · | |
| Operating Cash Flow | $2.32B | $2.30B | $2.90B | $3.00B | $3.02B | $1.23B | $1.80B | $2.34B | |
| CapEx | $379M | $326M | $377M | $406M | $457M | $243M | $213M | $252M | |
| Investing Cash Flow | $-428M | $1.80B | $-864M | $1.47B | $-118M | $-301M | $-525M | $-1.21B | |
| Debt Issued | $0 | $0 | $300.0K | $1.88B | $1.71B | $983M | $7M | $2.58B | |
| Net Debt Issued | $-100.0K | · | · | · | · | · | · | · | |
| Stock Issued | $3M | $2M | $3M | $3M | $0 | $0 | · | · | |
| Stock Repurchased | $500M | $250M | $250M | $0 | $0 | $0 | $0 | $432M | |
| Net Stock Activity | $-498M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-1.29B | $-4.33B | $-2.30B | $-3.88B | $-3.01B | $-606M | $-1.17B | $-1.09B | |
| Net Change in Cash | $612M | $-258M | $-269M | $556M | $-144M | $359M | $102M | $19M | |
| Taxes Paid | $445M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.94B | · | · | · | · | · | · | · | |
| Levered FCF | $1.49B | · | · | · | · | · | · | · |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.1% | · | · | · | · | · | · | · | |
| Operating Margin | -18.6% | · | · | · | · | · | · | · | |
| Net Margin | -24.6% | · | · | · | · | · | · | · | |
| Pretax Margin | -25.6% | · | · | · | · | · | · | · | |
| EBITDA Margin | 0.95% | · | · | · | · | · | · | · | |
| ROA | -8.9% | · | · | · | · | · | · | · | |
| ROE | -23.2% | · | · | · | · | · | · | · | |
| ROIC | -8.8% | · | · | · | · | · | · | · |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | · | · | · | · | · | · | · | |
| Quick Ratio | 0.6 | · | · | · | · | · | · | · | |
| Debt / Equity | 1.0 | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.8 | · | · | · | · | · | · | · | |
| Interest Coverage | -5.7 | · | · | · | · | · | · | · |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | · | · | · | · | · | · | · | |
| Inventory Turnover | 2.4 | · | · | · | · | · | · | · | |
| Receivables Turnover | 4.6 | · | · | · | · | · | · | · |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | $0.00 | · | |
| Dividend Paid / Share | $0.48 | $0.48 | $0.48 | $0.48 | $0.33 | · | · | · | |
| EPS (TTM) | $-3.00 | $-0.53 | $0.05 | $1.71 | $-1.05 | $-1.11 | $0.03 | · |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -3.0% | -4.5% | -5.1% | -9.1% | 49.7% | · | · | · | |
| Revenue CAGR 3Y | -4.2% | -6.2% | 8.9% | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.7% | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -97.1% | · | · | · | · | · | |
| Net Income YoY | · | · | -97.4% | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.30B | $14.74B | $15.43B | $16.26B | $17.89B | $11.95B | $11.50B | · | |
| Net Income TTM | $-3.51B | $-634M | $55M | $2.08B | $-1.27B | $-670M | $17M | · | |
| Market Cap | · | · | · | · | · | · | $2.0K | · | |
| P/E | -4.2 | -23.5 | 216.6 | 6.5 | -12.9 | -16.9 | 670.0 | · | |
| P/S | · | · | · | · | · | · | 0.0 | · | |
| Earnings Yield | -24.1% | -4.3% | 0.46% | 15.4% | -7.8% | -5.9% | 0.15% | · |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.76B | $3.52B | $3.70B | $3.76B | $3.58B | $3.25B | $3.53B | $3.75B | $3.80B | $3.66B | $3.84B | $3.94B | $3.92B | $3.73B | $3.88B | $4.08B | |
| Cost of Revenue | $2.30B | $2.36B | $2.56B | $2.39B | $2.25B | $2.09B | $2.31B | $2.29B | $2.35B | $2.16B | $2.24B | $2.25B | $2.31B | $2.19B | $2.60B | $2.33B | |
| Gross Profit | $1.46B | $1.16B | $1.15B | $1.37B | $1.33B | $1.16B | $1.22B | $1.46B | $1.45B | $1.50B | $1.60B | $1.69B | $1.61B | $1.54B | $1.27B | $1.75B | |
| R&D Expense | $248M | $249M | · | $250M | $219M | $222M | · | $198M | $204M | $200M | · | $211M | $208M | $183M | · | $175M | |
| SG&A Expense | $1.13B | $929M | $1.03B | $887M | $929M | $948M | $1.05B | $1.00B | $1.04B | $1.02B | $1.03B | $1.05B | $1.03B | $959M | $1.27B | $1.02B | |
| Operating Expenses | $1.45B | $1.24B | $1.34B | $1.19B | $1.10B | $4.04B | $1.39B | $1.23B | $1.69B | $1.30B | $2.05B | $1.24B | $1.24B | $1.14B | $1.48B | $1.19B | |
| Operating Income | $6M | $-80M | $-193M | $179M | $233M | $-2.88B | $-180M | $226M | $-240M | $204M | $-454M | $452M | $369M | $400M | $-201M | $560M | |
| Interest Expense | $121M | $120M | $120M | $120M | $117M | $116M | $120M | $146M | $146M | $138M | $141M | $142M | $144M | $147M | $147M | $153M | |
| Other Non-op | $50M | $-48M | $-31M | $-67M | $-334M | $-99M | $-226M | $10M | $-6M | $139M | $-260M | $92M | $108M | $70M | $1.82B | $21M | |
| Pretax Income | $-64M | $-247M | $-343M | $-8M | $-217M | $-3.10B | $-526M | $90M | $-392M | $205M | $-855M | $402M | $333M | $323M | $1.47B | $428M | |
| Income Tax | $55M | $-424M | $-3M | $120M | $-212M | $-55M | $-10M | $-4M | $-65M | $91M | $-89M | $71M | $69M | $98M | $458M | $73M | |
| EPS (Basic) | $-0.10 | $0.15 | $-0.34 | $-0.11 | $0.00 | $-2.55 | $-0.44 | $0.08 | $-0.27 | $0.10 | $-0.64 | $0.28 | $0.22 | $0.19 | $0.83 | $0.29 | |
| EPS (Diluted) | $-0.10 | $0.15 | $-0.34 | $-0.11 | $0.00 | $-2.55 | $-0.43 | $0.08 | $-0.27 | $0.09 | $-0.63 | $0.27 | $0.22 | $0.19 | $0.83 | $0.29 | |
| Shares (Basic) | 1,163,300,000 | 1,155,400,000 | · | 1,164,600,000 | 1,173,000,000 | 1,192,400,000 | · | 1,193,500,000 | 1,191,100,000 | 1,195,200,000 | · | 1,199,500,000 | 1,199,000,000 | 1,202,500,000 | · | 1,212,500,000 | |
| Shares (Diluted) | 1,163,300,000 | 1,175,300,000 | · | 1,164,600,000 | 1,173,000,000 | 1,192,400,000 | · | 1,200,400,000 | 1,191,100,000 | 1,209,500,000 | · | 1,207,600,000 | 1,203,500,000 | 1,205,600,000 | · | 1,218,100,000 | |
| EBITDA | $6M | $596M | · | $179M | $233M | $-2.22B | · | $226M | $-240M | $895M | · | $452M | $369M | $1.13B | · | $560M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $886M | $1.80B | $1.32B | $975M | $566M | $755M | $735M | $1.88B | $917M | $1.01B | $992M | $1.31B | $629M | $507M | $1.26B | $647M | |
| Receivables | $3.13B | $3.08B | $3.03B | $3.37B | $3.26B | $3.13B | $3.22B | $3.72B | $3.57B | $3.63B | · | $3.74B | $3.61B | $3.50B | · | $3.33B | |
| Inventory | $3.93B | $3.93B | $4.00B | $4.11B | $4.26B | $4.10B | $3.85B | $4.08B | $3.94B | $3.82B | · | $3.67B | $3.64B | $3.66B | · | $3.38B | |
| Prepaid Expense | $2.11B | $2.11B | $1.44B | $1.49B | $1.69B | $1.65B | $1.71B | $1.63B | $1.76B | $1.93B | · | $1.78B | $1.73B | $1.76B | · | $1.70B | |
| Other Current Assets | $140M | $98M | $136M | $251M | $259M | $355M | $387M | $335M | $270M | $250M | · | $1.20B | $1.18B | $1.35B | · | $1.13B | |
| Current Assets | $10.06B | $10.92B | $9.79B | $9.95B | $9.77B | $9.62B | $9.52B | $11.31B | $11.79B | $12.92B | · | $10.93B | $9.78B | $9.63B | · | $10.49B | |
| PP&E (Net) | $2.44B | $2.53B | $2.61B | $2.63B | $2.64B | $2.64B | $2.67B | $2.68B | $2.66B | $2.71B | · | $2.93B | $2.98B | $3.01B | · | $3.04B | |
| PP&E (Gross) | $5.11B | $5.11B | $5.13B | $5.11B | $5.07B | $4.94B | $4.87B | $4.88B | $4.71B | $4.71B | · | $5.04B | $5.05B | $5.15B | · | $5.02B | |
| Accum. Depreciation | $2.67B | $2.58B | $2.52B | $2.48B | $2.42B | $2.30B | $2.20B | $2.21B | $2.05B | $2.00B | · | $2.11B | $2.06B | $2.14B | · | $1.98B | |
| Goodwill | $6.65B | $6.69B | $6.75B | $6.73B | $6.75B | $6.46B | $9.13B | $9.56B | $9.33B | $9.69B | $9.87B | $10.28B | $10.53B | $10.57B | $10.43B | $10.05B | |
| Intangibles | $13.68B | $14.48B | $15.10B | $15.72B | $16.32B | $16.66B | $17.07B | $17.98B | $18.42B | $19.13B | · | $21.28B | $22.08B | $22.70B | · | $23.01B | |
| Other Non-current Assets | $1.06B | $1.11B | $1.87B | $1.89B | $2.00B | $2.27B | $2.36B | $2.47B | $2.45B | $2.23B | · | $2.40B | $2.35B | $2.42B | · | $964M | |
| Total Assets | $35.04B | $36.83B | $37.19B | $37.92B | $38.41B | $38.47B | $41.50B | $44.75B | $45.33B | $47.34B | · | $48.74B | $48.70B | $49.29B | · | $48.66B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $23M | $205M | · | $500M | |
| Current Liabilities | $6.35B | $6.81B | $7.09B | $7.36B | $7.13B | $5.72B | $5.78B | $7.51B | $7.71B | $7.76B | · | $6.83B | $6.52B | $6.11B | · | $6.52B | |
| Capital Leases | $160M | $167M | $178M | $171M | $182M | $177M | $179M | $188M | $192M | $156M | · | $160M | $167M | $173M | · | $179M | |
| Deferred Tax | $803M | $871M | $892M | $1.03B | $1.08B | $1.08B | $1.11B | $1.28B | $1.57B | $1.67B | · | $2.32B | $2.41B | $2.46B | · | $2.49B | |
| Other Non-current Liabilities | $2.02B | $2.08B | $2.01B | $1.82B | $1.84B | $1.84B | $1.94B | $1.87B | $1.80B | $1.83B | · | $1.65B | $1.67B | $1.72B | · | $1.75B | |
| Total Liabilities | $20.78B | $22.18B | $22.48B | $22.70B | $22.84B | $22.82B | $22.87B | $24.96B | $25.81B | $27.33B | · | $27.88B | $27.85B | $28.36B | · | $29.48B | |
| Long-term Debt | $13.35B | $14.34B | $14.41B | $14.44B | $14.47B | $14.19B | $14.05B | $15.75B | $17.10B | $17.97B | · | $18.38B | $18.58B | $18.58B | · | $19.49B | |
| Total Debt | $13.35B | $14.34B | · | $14.44B | $14.47B | $14.19B | · | $15.75B | $17.10B | $17.97B | · | $18.38B | $18.60B | $18.78B | · | $19.99B | |
| Common Stock | $13M | $13M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | |
| Paid-in Capital | $18.56B | $18.66B | $18.80B | $18.89B | $19.00B | $18.96B | $18.92B | $18.89B | $18.85B | $18.84B | · | $18.76B | $18.72B | $18.68B | · | $18.62B | |
| Retained Earnings | $-331M | $-212M | $-388M | $-48M | $80M | $228M | $3.42B | $4.08B | $4.13B | $4.61B | · | $5.55B | $5.37B | $5.25B | · | $4.31B | |
| Treasury Stock | $1.16B | $1.01B | $1.01B | $924M | $856M | $680M | $504M | $504M | $504M | $504M | · | $252M | $252M | $252M | · | · | |
| AOCI | $-2.82B | $-2.80B | $-2.71B | $-2.71B | $-2.66B | $-2.87B | · | $-2.69B | $-2.98B | $-2.94B | · | $-3.21B | $-3.01B | $-2.76B | · | $-3.76B | |
| Stockholders' Equity | $14.26B | $14.66B | $14.71B | $15.22B | $15.57B | $15.65B | $18.64B | $19.79B | $19.52B | $20.01B | $20.47B | $20.87B | $20.84B | $20.93B | $21.07B | $19.18B | |
| Liabilities + Equity | $35.04B | $36.83B | $37.19B | $37.92B | $38.41B | $38.47B | $41.50B | $44.75B | $45.33B | $47.34B | · | $48.74B | $48.70B | $49.29B | · | $48.66B |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $672M | $676M | $767M | $688M | $678M | $665M | $746M | $670M | $786M | $691M | $644M | $679M | $687M | $730M | $870M | $700M | |
| Stock-based Comp | $39M | $48M | $49M | $36M | $37M | $55M | $32M | $32M | $35M | $47M | $56M | $43M | $39M | $43M | $30M | $29M | |
| Deferred Tax | $-124M | $-70M | $-248M | $-137M | $-48M | $-44M | $-249M | $-312M | $-154M | $-52M | $-207M | $-85M | $-68M | $-27M | $154M | $-22M | |
| Amort. of Intangibles | $572M | $585M | $602M | $593M | $583M | $571M | $579M | $575M | $597M | $601M | $539M | $584M | $591M | $603M | $606M | $616M | |
| Restructuring | $27M | $78M | · | · | · | · | · | · | · | · | · | $15M | $74M | $10M | · | $15M | |
| Operating Cash Flow | $382M | $388M | $816M | $745M | $220M | $536M | $483M | $826M | $379M | $615M | $568M | $845M | $525M | $971M | $189M | $869M | |
| CapEx | $53M | $40M | $196M | $87M | $53M | $43M | $140M | $77M | $59M | $50M | $166M | $96M | $68M | $48M | $154M | $104M | |
| Investing Cash Flow | $-52M | $277M | $-211M | $-99M | $-52M | $-65M | $-169M | $1.75B | $376M | $-154M | $27M | $-65M | $-87M | $-750M | $1.74B | $-115M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $300.0K | $0 | $0 | $0 | $100.0K | $1.08B | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-750M | · | · | |
| Stock Issued | $700.0K | $500.0K | $600.0K | $700.0K | $700.0K | $600.0K | $600.0K | $600.0K | $700.0K | $600.0K | $600.0K | $800.0K | $800.0K | $900.0K | $800.0K | $2M | |
| Stock Repurchased | $150M | $0 | $82M | $68M | $175M | $175M | $0 | $0 | $0 | $250M | $0 | $0 | $0 | $250M | $0 | $0 | |
| Net Stock Activity | · | $500.0K | · | $-68M | $-175M | $-175M | · | · | · | $-249M | · | · | · | $-249M | · | · | |
| Financing Cash Flow | $-1.24B | $-204M | $-236M | $-228M | $-362M | $-467M | $-1.42B | $-1.64B | $-848M | $-426M | $-926M | $-98M | $-304M | $-975M | $-1.33B | $-759M | |
| Net Change in Cash | $-916M | $458M | $344M | $436M | $-188M | $20M | $-1.14B | $962M | $-97M | $22M | $-318M | $680M | $121M | $-752M | $612M | $-19M | |
| Free Cash Flow | · | $348M | · | · | · | $493M | · | · | · | $565M | · | · | · | $923M | · | · | |
| Levered FCF | · | $434M | · | · | · | $379M | · | · | · | $488M | · | · | · | $821M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.8% | 32.9% | · | 36.5% | 37.2% | 35.7% | · | 38.9% | 38.1% | 41.0% | · | 42.9% | 41.0% | 41.4% | · | 42.9% | |
| Operating Margin | 0.17% | -2.3% | · | 4.8% | 6.5% | -88.6% | · | 6.0% | -6.3% | 5.6% | · | 11.5% | 9.4% | 10.7% | · | 13.7% | |
| Pretax Margin | -1.7% | -7.0% | · | -0.21% | -6.1% | -95.2% | · | 2.4% | -10.3% | 5.6% | · | 10.2% | 8.5% | 8.6% | · | 10.5% | |
| EBITDA Margin | 0.17% | 17.0% | · | 4.8% | 6.5% | -68.1% | · | 6.0% | -6.3% | 24.4% | · | 11.5% | 9.4% | 30.3% | · | 13.7% | |
| ROIC | 0.04% | 0.20% | · | 9.8% | 0.02% | -9.5% | · | 0.67% | -0.55% | 0.30% | · | 0.95% | 0.74% | 0.70% | · | 1.2% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.6 | · | 1.4 | 1.4 | 1.7 | · | 1.5 | 1.5 | 1.7 | · | 1.6 | 1.5 | 1.6 | · | 1.6 | |
| Quick Ratio | 0.6 | 0.7 | · | 0.6 | 0.5 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.7 | 0.6 | 0.7 | · | 0.6 | |
| Debt / Equity | 0.9 | 1.0 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | |
| LT Debt / Equity | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.9 | · | 0.7 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.9 | · | 1.0 | |
| Interest Coverage | 0.1 | -0.7 | · | 1.5 | 2.0 | -25.0 | · | 1.6 | -1.6 | 1.5 | · | 3.2 | 2.6 | 2.7 | · | 3.7 |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Receivables Turnover | 1.2 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 1.1 | 1.0 | · | 1.1 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $3.23 | $2.99 | · | $3.23 | $3.05 | $2.73 | · | $3.12 | $3.19 | $3.03 | · | · | · | $3.09 | · | $3.35 | |
| Cash Flow / Share | · | $0.33 | · | · | · | $0.45 | · | · | · | $0.51 | · | · | · | $0.81 | · | · | |
| Dividend / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.12 | |
| Dividend Paid / Share | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | |
| EPS (TTM) | $-0.40 | $-0.30 | · | $-3.09 | $-2.90 | $-3.17 | · | $-0.73 | $-0.54 | $-0.05 | · | $1.51 | $1.53 | $1.57 | · | $0.66 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.74B | $14.56B | · | $14.12B | $14.12B | $14.33B | · | $15.05B | $15.24B | $15.36B | · | $15.47B | $15.60B | $15.80B | · | $16.73B | |
| Net Income TTM | $-670M | $-670M | · | $-670M | $-670M | $-670M | · | $-670M | $-670M | $-670M | · | $-670M | $-670M | $-670M | · | $-670M | |
| P/E | -39.7 | -45.0 | · | -3.2 | -3.1 | -2.7 | · | -15.9 | -19.7 | -238.8 | · | 6.5 | 6.5 | 6.1 | · | 12.9 | |
| Earnings Yield | -2.5% | -2.2% | · | -31.2% | -32.5% | -36.4% | · | -6.3% | -5.1% | -0.42% | · | 15.3% | 15.3% | 16.3% | · | 7.8% |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $14.30B | $14.74B | $15.43B | $16.26B | $17.89B |
| सकल मार्जिन % | 35.1% | · | · | · | · |
| परिचालन मार्जिन % | -18.6% | · | · | · | · |
| शुद्ध आय | $-3.51B | $-634M | $55M | $2.08B | $-1.27B |
| तनुकरणित EPS | $-3.00 | $-0.53 | $0.05 | $1.71 | $-1.05 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| ऋण / इक्विटी | 1.0 | · | · | · | · |
| वर्तमान अनुपात | 1.4 | · | · | · | · |
| त्वरित अनुपात | 0.6 | · | · | · | · |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $1.94B | · | · | · | · |
संस्थागत मालिक (13F) 1118 फाइलर्स · $17.2B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
धारक
1118
धारित मूल्य
$17.2B
नई स्थितियाँ
109
बाहर निकली पोजीशन
87
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 109 (-47 पिछली तिमाही की तुलना में) | 87 (-2 पिछली तिमाही की तुलना में) | 373 (+25 पिछली तिमाही की तुलना में) | 325 (+14 पिछली तिमाही की तुलना में) | +90.9M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1720339307 | 138179864 | 10.03% | शेयर |
| FMR LLC | $1534994190 | 96662102 | 8.95% | शेयर |
| BlackRock, Inc. | $1365989163 | 86019468 | 7.96% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $1207625391 | 76046939 | 7.04% | शेयर |
| Davis Selected Advisers | $1194789797 | 75232254 | 6.96% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $861999430 | 54282080 | 5.02% | शेयर |
| STATE STREET CORP | $842743041 | 53069461 | 4.91% | शेयर |
| Rubric Capital Management LP | $542599639 | 34168743 | 3.16% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $520097655 | 32807906 | 3.03% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $475964429 | 29970094 | 2.77% | शेयर |
| Invesco Ltd. | $329847848 | 20771275 | 1.92% | शेयर |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $320873980 | 20206170 | 1.87% | शेयर |
| AMERIPRISE FINANCIAL INC | $298795923 | 18815747 | 1.74% | शेयर |
| MORGAN STANLEY | $240246939 | 15128899 | 1.40% | शेयर |
| Bank of New York Mellon Corp | $226894280 | 14288053 | 1.32% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $215449390 | 13567342 | 1.26% | शेयर |
| GOLDMAN SACHS GROUP INC | $215410160 | 13564872 | 1.26% | शेयर |
| NORTHERN TRUST CORP | $159414412 | 10038691 | 0.93% | शेयर |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $156853255 | 9877409 | 0.91% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $132934942 | 8371218 | 0.77% | शेयर |
| Callodine Capital Management, LP | $127051783 | 8000742 | 0.74% | शेयर |
| DEUTSCHE BANK AG\ | $125313384 | 7891271 | 0.73% | शेयर |
| JPMORGAN CHASE & CO | $119690536 | 7322267 | 0.70% | शेयर |
| BANK OF AMERICA CORP /DE/ | $116824517 | 7356708 | 0.68% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $103910383 | 6543475 | 0.61% | शेयर |
| Qube Research & Technologies Ltd | $98141941 | 6180223 | 0.57% | शेयर |
| UBS Group AG | $96745659 | 6092296 | 0.56% | शेयर |
| Nuveen, LLC | $95398563 | 6007467 | 0.56% | शेयर |
| FRANKLIN RESOURCES INC | $89856011 | 5658439 | 0.52% | शेयर |
| JANE STREET GROUP, LLC | $88440659 | 5569311 | 0.52% | शेयर |
| Nantahala Capital Management, LLC | $79400000 | 5000000 | 0.46% | कॉल ऑप्शन |
| Assenagon Asset Management S.A. | $79225415 | 4989006 | 0.46% | शेयर |
| AQR CAPITAL MANAGEMENT LLC | $74556065 | 4694966 | 0.43% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $73760258 | 4644851 | 0.43% | शेयर |
| Gotham Asset Management, LLC | $69469966 | 4374683 | 0.40% | शेयर |
| CITIGROUP INC | $69243850 | 4360444 | 0.40% | शेयर |
| Brandywine Global Investment Management, LLC | $67528501 | 5423976 | 0.39% | शेयर |
| Legal & General Group Plc | $64625994 | 4069647 | 0.38% | शेयर |
| NORGES BANK | $60705175 | 3822744 | 0.35% | शेयर |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $59326092 | 3735900 | 0.35% | शेयर |
| Man Group plc | $55946065 | 3523052 | 0.33% | शेयर |
| Russell Investments Group, Ltd. | $54379234 | 3423675 | 0.32% | शेयर |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $53562152 | 3964630 | 0.31% | शेयर |
| Amundi | $51920530 | 3269550 | 0.30% | शेयर |
| SEI INVESTMENTS CO | $50267814 | 3165469 | 0.29% | शेयर |
| ROYAL BANK OF CANADA | $49792000 | 3135460 | 0.29% | शेयर |
| RHUMBLINE ADVISERS | $45614656 | 2872464 | 0.27% | शेयर |
| DME Capital Management, LP | $44042703 | 2773470 | 0.26% | शेयर |
| Vanguard Global Advisers, LLC | $42862486 | 2699149 | 0.25% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $42610407 | 2683275 | 0.25% | शेयर |
कंपनी के अंदरूनी सूत्र 32 इनसाइडर्स · 14 अधिकारी · 20 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Scott Andrew Smith | Chief Executive Officer | 6 मार्च 2026 A | 1329326 | 0 | 0 | $0 |
| Michael Goettler | Chief Executive Officer | 4 मार्च 2023 M | 321653 | 0 | 0 | $0 |
| Campbell Paul | Interim Chief Financial Officer, Chief Accounting Officer and Corporate Controller | 25 जून 2026 S | 316212 | 0 | 2 | $-1093257 |
| Theodora Mistras | Chief Financial Officer | 6 मार्च 2026 A | 70645 | 0 | 0 | $0 |
| Sanjeev Narula | Chief Financial Officer | 4 मार्च 2023 M | 73877 | 0 | 0 | $0 |
| Anthony Mauro | President, Developed Markets | 13 मार्च 2024 S | 243044 | 0 | 0 | $0 |
| Xiangyang (Sean) Ni | President, Greater China | 4 मार्च 2024 A | 90804 | 0 | 0 | $0 |
| Andrew Cuneo | President, JANZ (Japan, Australia and New Zealand) and Emerging Markets | 4 मार्च 2024 A | 60055 | 0 | 0 | $0 |
| Menassie Taddese | President, Emerging Markets | 27 मई 2022 S | 0 | 0 | 0 | $0 |
| Andrew Enrietti | Chief Administrative and Transformation Officer | 15 अगस्त 2026 M | 234444 | 0 | 0 | $0 |
| Corinne Le Goff | Chief Commercial Officer | 15 अप्रैल 2026 M | 107135 | 0 | 0 | $0 |
| Matthew Joseph Maletta | Chief Legal Officer | 6 मार्च 2026 A | · | 0 | 0 | $0 |
| Brian Roman | Chief Legal Officer | 6 मार्च 2025 A | 193916 | 0 | 0 | $0 |
| Robert J Coury | Executive Chairman | 4 मार्च 2023 M | 1174515 | 0 | 0 | $0 |
| Leo Frans Groothuis | निदेशक | 30 सितमबर 2026 A | 63437 | 0 | 0 | $0 |
| David S Simmons | निदेशक | 30 सितमबर 2026 A | 23344 | 2 | 0 | $5202 |
| Richard A Mark | निदेशक | 6 मार्च 2026 A | 116145 | 0 | 0 | $0 |
| Coelho Rogerio Vivaldi | निदेशक | 6 मार्च 2026 A | 46526 | 0 | 0 | $0 |
| Michael Severino | निदेशक | 6 मार्च 2026 A | 26031 | 0 | 0 | $0 |
| Dillon Joellen Lyons | निदेशक | 6 मार्च 2026 A | 102526 | 0 | 0 | $0 |
| Mark W Parrish | निदेशक | 6 मार्च 2026 A | 165230 | 0 | 0 | $0 |
| Elisha W Finney | निदेशक | 6 मार्च 2026 A | 62667 | 0 | 0 | $0 |
| Frank A Damelio | निदेशक | 6 मार्च 2026 A | 26031 | 0 | 0 | $0 |
| Don W Cornwell | निदेशक | 6 मार्च 2026 A | 112044 | 0 | 0 | $0 |
| Melina E Higgins | निदेशक | 6 मार्च 2026 A | 146048 | 0 | 0 | $0 |
| James M Kilts | निदेशक | 6 मार्च 2026 A | 161257 | 0 | 0 | $0 |
| Rajiv Malik | निदेशक | 6 मार्च 2025 A | 1068262 | 0 | 0 | $0 |
| Harry Korman | निदेशक | 6 मार्च 2025 A | 113937 | 0 | 0 | $0 |
| Mohr Pauline Van Der Meer | निदेशक | 4 मार्च 2023 M | 40245 | 0 | 0 | $0 |
| Ian C Read | निदेशक | 21 मार्च 2022 M | 14497 | 0 | 0 | $0 |
| Neil F Dimick | निदेशक | 21 मार्च 2022 M | 75200 | 0 | 0 | $0 |
| Pfizer Inc. | 10% मालिक | 16 नवमबर 2020 J | 0 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 123 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| DUSA · Davis Fundamental ETF Trust | 5.37% | 3886641 NS | 31 जुलाई 2026 | N-PORT |
| ADPV · Series Portfolios Trust | 4.75% | 482110 NS | 31 जुलाई 2026 | N-PORT |
| DWLD · Davis Fundamental ETF Trust | 4.37% | 1522109 NS | 31 जुलाई 2026 | N-PORT |
| IHE · iShares Trust | 4.36% | 4310454 SH | 11 सितमबर 2026 | दैनिक |
| PJP · Invesco Exchange-Traded Fund Trust | 3.40% | 1069356 SH | 2 अक्टूबर 2026 | दैनिक |
| CVSM · Elevation Series Trust | 2.66% | 143081 NS | 31 जुलाई 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 2.51% | 21853 NS | 31 जुलाई 2026 | N-PORT |
| SPDV · ETF Series Solutions | 2.41% | 180356 NS | 31 जुलाई 2026 | N-PORT |
| LYLD · Cambria ETF Trust | 2.03% | 8379 NS | 31 जुलाई 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.75% | 872739 SH | 2 अक्टूबर 2026 | दैनिक |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.50% | 896631 NS | 31 जुलाई 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1.34% | 81239 SH | 2 अक्टूबर 2026 | दैनिक |
| RPV · Invesco Exchange-Traded Fund Trust | 1.27% | 1218971 SH | 2 अक्टूबर 2026 | दैनिक |
| PILL · Direxion Shares ETF Trust | 1.27% | 14896 NS | 31 जुलाई 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 1.07% | 786966 NS | 31 जुलाई 2026 | N-PORT |
| SYLD · Cambria ETF Trust | 1.04% | 587982 NS | 31 जुलाई 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 1.02% | 118272 SH | 2 अक्टूबर 2026 | दैनिक |
| SPVM · Invesco Exchange-Traded Fund Trust | 0.80% | 60381 SH | 2 अक्टूबर 2026 | दैनिक |
| IQSM · New York Life Investments ETF Trust | 0.78% | 146604 NS | 31 जुलाई 2026 | N-PORT |
| CVY · Invesco Exchange-Traded Fund Trust | 0.74% | 49232 SH | 2 अक्टूबर 2026 | दैनिक |
| MEDI · Harbor ETF Trust | 0.57% | 13424 NS | 31 जुलाई 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 0.54% | 5774795 NS | 31 जुलाई 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.51% | 187532 NS | 31 जुलाई 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0.47% | 61211 NS | 31 जुलाई 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.43% | 113494 NS | 31 जुलाई 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.43% | 493425 NS | 31 जुलाई 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.39% | 16955526 SH | 19 अगस्त 2026 | दैनिक |
| FBCV · FIDELITY COVINGTON TRUST | 0.39% | 39217 NS | 31 जुलाई 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0.39% | 329029 NS | 31 जुलाई 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0.36% | 10810000 | 2 अक्टूबर 2026 | दैनिक |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.35% | 91816 NS | 31 जुलाई 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.35% | 2881753 NS | 31 जुलाई 2026 | N-PORT |
| IYH · iShares Trust | 0.31% | 680750 SH | 11 सितमबर 2026 | दैनिक |
| FHLC · FIDELITY COVINGTON TRUST | 0.30% | 554689 NS | 31 जुलाई 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.28% | 150960 SH | 19 अगस्त 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.27% | 3499976 SH | 19 अगस्त 2026 | दैनिक |
| ESML · iShares Trust | 0.27% | 455933 SH | 11 सितमबर 2026 | दैनिक |
| SMMD · iShares Trust | 0.26% | 621073 SH | 11 सितमबर 2026 | दैनिक |
| REVS · Columbia ETF Trust I | 0.26% | 49916 NS | 31 जुलाई 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0.26% | 115598 SH | 19 अगस्त 2026 | दैनिक |
| IMCV · iShares Trust | 0.26% | 182951 SH | 11 सितमबर 2026 | दैनिक |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.26% | 122266 NS | 31 जुलाई 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.25% | 194588 NS | 31 जुलाई 2026 | N-PORT |
| IXJ · iShares Trust | 0.24% | 611025 SH | 11 सितमबर 2026 | दैनिक |
| CURE · Direxion Shares ETF Trust | 0.23% | 22916 NS | 31 जुलाई 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.22% | 26707011 SH | 19 अगस्त 2026 | दैनिक |
| RSP · Invesco Exchange-Traded Fund Trust | 0.22% | 11840644 SH | 2 अक्टूबर 2026 | दैनिक |
| IWS · iShares Trust | 0.19% | 1735168 SH | 11 सितमबर 2026 | दैनिक |
| WSML · iShares Trust | 0.18% | 71909 SH | 11 सितमबर 2026 | दैनिक |
| RECS · Columbia ETF Trust I | 0.17% | 566625 NS | 31 जुलाई 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0.17% | 7873000 | 2 अक्टूबर 2026 | दैनिक |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0.16% | 228156 NS | 31 जुलाई 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.15% | 187618 SH | 19 अगस्त 2026 | दैनिक |
| LGDX · Tidal Trust III | 0.15% | 11980 NS | 31 जुलाई 2026 | N-PORT |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0.14% | 1929301 SH | 2 अक्टूबर 2026 | दैनिक |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.14% | 13535 NS | 31 जुलाई 2026 | N-PORT |
| IWR · iShares Trust | 0.14% | 4755593 SH | 11 सितमबर 2026 | दैनिक |
| IMCB · iShares Trust | 0.13% | 131500 SH | 10 सितमबर 2026 | दैनिक |
| DFVX · Dimensional ETF Trust | 0.12% | 36388 NS | 31 जुलाई 2026 | N-PORT |
| FBCG · FIDELITY COVINGTON TRUST | 0.11% | 438116 NS | 31 जुलाई 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.11% | 622740 SH | 2 अक्टूबर 2026 | दैनिक |
| XOEF · iShares Trust | 0.11% | 1446 SH | 11 सितमबर 2026 | दैनिक |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.10% | 55842 SH | 2 अक्टूबर 2026 | दैनिक |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 46150 SH | 2 अक्टूबर 2026 | दैनिक |
| DIVB · iShares Trust | 0.10% | 124028 SH | 11 सितमबर 2026 | दैनिक |
| DFUV · Dimensional ETF Trust | 0.09% | 825072 NS | 31 जुलाई 2026 | N-PORT |
| VYM · VANGUARD WHITEHALL FUNDS | 0.08% | 4647551 SH | 19 अगस्त 2026 | दैनिक |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.08% | 445218 SH | 2 अक्टूबर 2026 | दैनिक |
| DFLV · Dimensional ETF Trust | 0.07% | 272031 NS | 31 जुलाई 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.07% | 21814 NS | 31 जुलाई 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.06% | 1747680 NS | 31 जुलाई 2026 | N-PORT |
| IVE · iShares Trust | 0.06% | 1934171 SH | 11 सितमबर 2026 | दैनिक |
| IUSV · iShares Trust | 0.06% | 1017393 SH | 11 सितमबर 2026 | दैनिक |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.06% | 267075 SH | 19 अगस्त 2026 | दैनिक |
| DCOR · Dimensional ETF Trust | 0.06% | 110597 NS | 31 जुलाई 2026 | N-PORT |
| ILCV · iShares Trust | 0.05% | 44089 SH | 11 सितमबर 2026 | दैनिक |
| IWD · iShares Trust | 0.05% | 2579107 SH | 11 सितमबर 2026 | दैनिक |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.05% | 701858 SH | 19 अगस्त 2026 | दैनिक |
| DFAS · Dimensional ETF Trust | 0.04% | 358281 NS | 31 जुलाई 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.04% | 52351 NS | 31 जुलाई 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.04% | 267915 NS | 31 जुलाई 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.04% | 35780 SH | 2 अक्टूबर 2026 | दैनिक |
| TOPC · iShares Trust | 0.04% | 720 SH | 9 सितमबर 2026 | दैनिक |
| XRMI · Global X Funds | 0.04% | 1009 NS | 31 जुलाई 2026 | N-PORT |
| XYLG · Global X Funds | 0.03% | 1200 NS | 31 जुलाई 2026 | N-PORT |
| XVV · iShares Trust | 0.03% | 13227 SH | 11 सितमबर 2026 | दैनिक |
| XYLD · Global X Funds | 0.03% | 58008 NS | 31 जुलाई 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0.03% | 58253 NS | 31 जुलाई 2026 | N-PORT |
| XTR · Global X Funds | 0.03% | 85 NS | 31 जुलाई 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0.03% | 6830 SH | 2 अक्टूबर 2026 | दैनिक |
| TILT · FlexShares Trust | 0.03% | 37920 NS | 31 जुलाई 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.03% | 362786 NS | 31 जुलाई 2026 | N-PORT |
| XCLR · Global X Funds | 0.03% | 62 NS | 31 जुलाई 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.03% | 30255873 SH | 19 अगस्त 2026 | दैनिक |
| VTI · VANGUARD INDEX FUNDS | 0.03% | 36993850 SH | 19 अगस्त 2026 | दैनिक |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.03% | 192700 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.03% | 97596 SH | 19 अगस्त 2026 | दैनिक |
| ESGV · VANGUARD WORLD FUND | 0.03% | 262709 SH | 19 अगस्त 2026 | दैनिक |
| TOV · EA Series Trust | 0.03% | 4573 NS | 31 जुलाई 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0.03% | 4394 NS | 31 जुलाई 2026 | N-PORT |
| IVV · iShares Trust | 0.03% | 14678463 SH | 11 सितमबर 2026 | दैनिक |
| QDPL · Pacer Funds Trust | 0.03% | 28053 NS | 31 जुलाई 2026 | N-PORT |
| ILCB · iShares Trust | 0.03% | 21777 SH | 11 सितमबर 2026 | दैनिक |
| IWB · iShares Trust | 0.03% | 814020 SH | 11 सितमबर 2026 | दैनिक |
| IYY · iShares Trust | 0.03% | 49059 SH | 11 सितमबर 2026 | दैनिक |
| LRGF · iShares Trust | 0.03% | 59492 SH | 11 सितमबर 2026 | दैनिक |
| ITOT · iShares Trust | 0.03% | 1524327 SH | 11 सितमबर 2026 | दैनिक |
| IWV · iShares Trust | 0.03% | 315944 SH | 11 सितमबर 2026 | दैनिक |
| HCMT · Direxion Shares ETF Trust | 0.03% | 8100 NS | 31 जुलाई 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0.02% | 863 SH | 2 अक्टूबर 2026 | दैनिक |
| SPXL · Direxion Shares ETF Trust | 0.02% | 91048 NS | 31 जुलाई 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.02% | 993914 SH | 19 अगस्त 2026 | दैनिक |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.02% | 41836 SH | 2 अक्टूबर 2026 | दैनिक |
| PTH · Invesco Exchange-Traded Fund Trust | 0.00% | 89 SH | 2 अक्टूबर 2026 | दैनिक |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 जुलाई 2026 | दैनिक |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 जुलाई 2026 | दैनिक |
| BNDX · VANGUARD CHARLOTTE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCEB · VANGUARD WORLD FUND | · | · | 30 जुलाई 2026 | दैनिक |
VTRS विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
रेटिंग · 17 विश्लेषक
खरीदें
मध्यिका लक्ष्य
$20.00
+13.6%
4 23.5%
मजबूत खरीद
7 41.2%
खरीदें
5 29.4%
होल्ड
1 5.9%
बेचें
0 0.0%
मजबूत बिक्री
12-महीने का मूल्य लक्ष्य
10 विश्लेषक · 2026-09-30माध्य लक्ष्य $19.40 +10.2%
अभी
वर्तमान मूल्य $17.60
निम्न$13.00
माध्य$19.40
उच्च$25.00
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| VTRS | · | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| MRK | · | 14.5 | 1.3% | 28.1% | 36.9% | · |
| PFE | · | 18.3 | -1.7% | 12.4% | 8.9% | · |
| BMY | · | 15.6 | -0.22% | 14.6% | 40.5% | · |
| RPRX | · | 21.7 | 5.1% | 32.4% | 8.0% | · |
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | · |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | · |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
$24 मिलियन के मेडिकल डिवाइस स्टॉक से 9% नीचे आने वाले स्टॉक से निवेशकों को क्या पता होना चाहिए
Nasdaq · 6 months, 1 week पहले
Viatris आउटलाइन लॉन्ग-टर्म फाइनेंशियल टारगेट्स
Nasdaq · 6 months, 2 weeks पहले
वायट्रिस इंक (VTRS) स्टॉक के बारे में विश्लेषक क्या कह रहे हैं?
Yahoo Finance · 6 months, 2 weeks पहले
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
स्रोत: SEC 10-Q अग 6, 2026 को फाइल किया गया